Physician profile
Jack Choueka
NPI 1659447399
$2,334.46
in general payments reported to CMS, 2019-2025
13 companies · $46.86 in 2025
The $46.86 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $537 · 2020: $278 · 2021: $57.30 · 2022: $367 · 2023: $125 · 2024: $922 · 2025: $46.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $726 · Travel and Lodging: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $726.18 |
| Travel and Lodging | $368.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Skeletal Dynamics INC | $490.79 | 2020-2024 | Align, Implate, Geminus |
| Endo Pharmaceuticals INC. | $450.01 | 2019-2024 | Xiaflex |
| Suvon Surgical LLC | $368.17 | 2024 | |
| Zimmer Biomet Holdings, INC. | $232.27 | 2019-2020 | |
| Stryker Corporation | $213.79 | 2019-2023 | Blueprint Patient Specific Instrumentation |
| Boston Scientific Corporation | $162.15 | 2022 | |
| Nevro Corp. | $145.80 | 2019 | |
| Endo USA, INC. | $86.38 | 2024-2025 | Xiaflex |
| Fidia Pharma USA INC. | $73.21 | 2022-2025 | Hymovis, Hyalgan, Triluron |
| Djo, LLC | $45.09 | 2024 | Cmf |
| Bioventus LLC | $25.85 | 2022 | |
| Arthrex, INC. | $24.00 | 2024 | |
| Daiichi Sankyo INC. | $16.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Choueka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.